e-learning
resources
Vienna 2012
Sunday, 02.09.2012
Technology, screening and questionnaires in OSA
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Screening of sleep apnea-hypopnea syndrome in patients with type 2 diabetes
D. Neves, J. Romero, K. Cunha, D. Torrado, H. Boavida, U. Brito (Faro, Portugal)
Source:
Annual Congress 2012 - Technology, screening and questionnaires in OSA
Session:
Technology, screening and questionnaires in OSA
Session type:
Thematic Poster Session
Number:
904
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Neves, J. Romero, K. Cunha, D. Torrado, H. Boavida, U. Brito (Faro, Portugal). Screening of sleep apnea-hypopnea syndrome in patients with type 2 diabetes. Eur Respir J 2012; 40: Suppl. 56, 904
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Static lung volumes and spirometry measurements
Panel discussion: The role of pharmacotherapy connected to OSA pathophysiological traits
Expert interview ERS guideline on non-CPAP therapies in obstructive sleep apnoea
Related content which might interest you:
Prevalence of obstructive sleep apnoea in men with type 2 diabetes
Source: Eur Respir J 2005; 26: Suppl. 49, 567s
Year: 2005
The relationship between obstructive sleep apnea hypopnea syndrome and insulin resistance, vascular complications in patients with type 2 diabetes mellitus
Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects I
Year: 2011
Sleep apnea screening questionnaires in patients with type 2 diabetes.
Source: International Congress 2018 – Diagnostics including questionnaires
Year: 2018
The impact of obstructive sleep apnea (OSA) severity on type 2 diabetes prevalence
Source: Sleep and Breathing Conference 2021
Year: 2021
Obstructive sleep apnoea in patients with type 1 diabetes
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013
Screening for obstructive sleep apnoea (OSA) in patients attending a hypertension clinic with features of the metabolic syndrome
Source: Annual Congress 2012 - Snoring and scoring: subjective and objective measures of sleep-disordered breathing
Year: 2012
High prevalence of obstructive sleep apnea syndrome in a type 1 diabetic adult population: A pilot study
Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea
Year: 2010
Obstructive sleep apnoea syndrome (OSAS) and diabetes: influence of obesity
Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea
Year: 2008
Cystatin C as a marker of cardiovascular diseases in patients with obstructive sleep apnea (OSA) with concomitant diabetes mellitus type 2 (DM2)
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013
The clinical presentation of obstructive sleep apnea syndrome is different in diabetic patients
Source: International Congress 2016 – Effect of sleep apnoea on life-span and comorbidities
Year: 2016
Frequency and predictors of obesity hypoventilation syndrome in morbidly obese (BMI ≥40) patients with obstructive sleep apnea syndrome
Source: Annual Congress 2013 –Sleep disordered breathing in special situations II
Year: 2013
Prevalence of residual sleepiness in patients with optimally treated sleep apnea syndrome (OSAS)
Source: Eur Respir J 2005; 26: Suppl. 49, 724s
Year: 2005
Prevalence of arterial hypertension in obstructive sleep apnoea (OSA) patients – Impact of diabetes and obesity
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013
Prevalence of metabolic syndrome with obstructive sleep apnea in a Korean population
Source: Annual Congress 2013 –Sleep disordered breathing in special situations III
Year: 2013
Prevalence of obesity hypoventilation syndrome in OSA patients in the UAE
Source: Annual Congress 2013 –Sleep disordered breathing in special situations III
Year: 2013
Type 2 diabetes and the risk for obstructive sleep apnoea in Nigeria
Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults III: questionnaires, epidemiology and sleep studies
Year: 2015
Sleep apnea-hypopnea syndrome in elderly obese patients : clinical and functional profiles
Source: International Congress 2018 – Sleep and breathing control: phenotypes
Year: 2018
Obstructive sleep apnoea and incident diabetes mellitus in a Chinese population
Source: International Congress 2017 – Lung function, respiratory symptoms and obstructive sleep apnoea
Year: 2017
Prevalence of the metabolic syndrome in untreated Mediterranean patients with the obstructive sleep apnea syndrome (OSAS)
Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea
Year: 2009
Prevalence of metabolic syndrome in patients with hypertension and obstructive sleep apnea
Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept